SI1435976T1 - Farmacevtski sestavek, ki obsega hito-oligomere - Google Patents
Farmacevtski sestavek, ki obsega hito-oligomereInfo
- Publication number
- SI1435976T1 SI1435976T1 SI200230558T SI200230558T SI1435976T1 SI 1435976 T1 SI1435976 T1 SI 1435976T1 SI 200230558 T SI200230558 T SI 200230558T SI 200230558 T SI200230558 T SI 200230558T SI 1435976 T1 SI1435976 T1 SI 1435976T1
- Authority
- SI
- Slovenia
- Prior art keywords
- oligomers
- chito
- treatment
- pharmaceutical composition
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000012659 Joint disease Diseases 0.000 abstract 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- 229920002101 Chitin Polymers 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 230000006196 deacetylation Effects 0.000 abstract 1
- 238000003381 deacetylation reaction Methods 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Biotechnology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS6085A IS6085A (is) | 2001-09-26 | 2001-09-26 | Lyfjablanda með kítósan óligómerum |
| EP02777769A EP1435976B1 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical composition comprising chito-oligomers |
| PCT/IS2002/000016 WO2003026677A1 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical composition comprising chito-oligomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1435976T1 true SI1435976T1 (sl) | 2007-08-31 |
Family
ID=36700489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230558T SI1435976T1 (sl) | 2001-09-26 | 2002-09-26 | Farmacevtski sestavek, ki obsega hito-oligomere |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7985741B2 (enExample) |
| EP (1) | EP1435976B1 (enExample) |
| JP (1) | JP4613008B2 (enExample) |
| KR (1) | KR20040062548A (enExample) |
| AT (1) | ATE359797T1 (enExample) |
| CA (1) | CA2507926C (enExample) |
| DE (1) | DE60219653T2 (enExample) |
| DK (1) | DK1435976T3 (enExample) |
| ES (1) | ES2284935T3 (enExample) |
| IS (2) | IS6085A (enExample) |
| PT (1) | PT1435976E (enExample) |
| SI (1) | SI1435976T1 (enExample) |
| WO (1) | WO2003026677A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003054208A2 (en) * | 2001-12-13 | 2003-07-03 | Ism Biopolymer Inc. | Method of modulating release of saccharides and uses thereof |
| GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
| EP1670486A4 (en) * | 2003-10-01 | 2009-04-01 | Optimer Pharmaceuticals Inc | TREATMENT OF A CONDITION IN A MAMMALIAN WITH ADMINISTRATION OF AMINO SUGAR AND USES THEREOF |
| WO2005051326A2 (en) * | 2003-11-24 | 2005-06-09 | Optimer Pharmaceuticals, Inc. | Treatment of a condition in a mammal with administration of compounds and methods of use thereof |
| JP4496375B2 (ja) * | 2004-05-21 | 2010-07-07 | 国立大学法人鳥取大学 | 創傷の治療又は処置のための薬剤 |
| JP5632125B2 (ja) * | 2005-06-14 | 2014-11-26 | ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． | 部分的脱アセチル化キチン誘導体の組成物 |
| US7485718B2 (en) | 2005-06-16 | 2009-02-03 | E. I. Du Pont De Nemours And Company | Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines |
| WO2007001282A2 (en) * | 2005-06-16 | 2007-01-04 | E.I. Dupont De Nemours And Company | Low molecular weight polyglucosamines and polygalactosamines |
| KR100831335B1 (ko) * | 2006-06-22 | 2008-05-22 | 부경대학교 산학협력단 | 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제 |
| WO2010007631A1 (en) * | 2008-07-18 | 2010-01-21 | Genis Ehf. | New composition for treating autoimmune disorders |
| KR20100060634A (ko) * | 2008-11-28 | 2010-06-07 | (주)아모레퍼시픽 | 미토콘드리아 활성화를 위한 조성물 |
| KR101729137B1 (ko) * | 2009-07-28 | 2017-04-26 | (주)아모레퍼시픽 | 키토올리고당을 함유하는 피로회복용 조성물 |
| MX368764B (es) | 2011-06-03 | 2019-10-15 | Maguire Abbey Llc | Método, composición, y artículos para mejorar la lubricación de articulación. |
| AR090026A1 (es) | 2011-09-08 | 2014-10-15 | Novozymes Bioag As | Metodos y composiciones para tratamiento de semillas |
| EP2748123B1 (en) | 2011-09-14 | 2023-11-08 | Novozymes Bioag A/S | Use of lipochito-oligosaccharides and/or chito oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth |
| UA114299C2 (uk) | 2011-09-23 | 2017-05-25 | Новозаймс Біоаг А/С | Хітоолігосахариди та способи застосування при стимулюванні росту рослин |
| MX2014003411A (es) * | 2011-09-23 | 2015-03-19 | Novozymes Bioag As | Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz. |
| CN104470550A (zh) | 2012-04-23 | 2015-03-25 | 杰尼斯公共有限公司 | 作为骨移植替代物的含有部分脱乙酰壳多糖的自硬化生物活性接合剂组合物 |
| JP6285497B2 (ja) * | 2016-06-07 | 2018-02-28 | 株式会社エバーライフ | 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法 |
| KR101673368B1 (ko) | 2016-07-14 | 2016-11-08 | 김기혁 | 공정가스 반응물의 콜드트랩 장치 |
| WO2023205718A2 (en) * | 2022-04-21 | 2023-10-26 | Hassan Ameer E | Methods of treating inflammation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5919122B2 (ja) * | 1976-10-12 | 1984-05-02 | 味の素株式会社 | 水溶性部分脱アセチル化キチン及びその製造法 |
| US4532134A (en) * | 1981-04-06 | 1985-07-30 | Malette William Graham | Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound |
| JP2527317B2 (ja) * | 1986-12-19 | 1996-08-21 | ライオン株式会社 | 骨疾患治療剤 |
| US6184037B1 (en) * | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| DE69733089T2 (de) * | 1996-12-13 | 2005-09-29 | Lescarden Inc. | Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin |
| JP3062592B2 (ja) * | 1997-05-30 | 2000-07-10 | 農林水産省食品総合研究所長 | ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法 |
| US6492350B2 (en) * | 2000-01-27 | 2002-12-10 | Jdc (Hawaii) Inc. | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain |
| EP1127574A1 (en) * | 2000-02-22 | 2001-08-29 | Food Industry Research and Development Institute | Use of chitinous materials for inhibiting cellular nitric oxide production |
| CA2313836C (en) * | 2000-03-15 | 2009-06-09 | Cargill, Incorporated | Chitosan and method of preparing chitosan |
| US20020119949A1 (en) * | 2001-02-26 | 2002-08-29 | Asa Hellman | Prophylactic teat treatment |
| JP5632125B2 (ja) | 2005-06-14 | 2014-11-26 | ジェニス イーエイチエフ．Ｇｅｎｉｓ ｅｈｆ． | 部分的脱アセチル化キチン誘導体の組成物 |
-
2001
- 2001-09-26 IS IS6085A patent/IS6085A/is unknown
-
2002
- 2002-09-26 KR KR10-2004-7004323A patent/KR20040062548A/ko not_active Ceased
- 2002-09-26 ES ES02777769T patent/ES2284935T3/es not_active Expired - Lifetime
- 2002-09-26 AT AT02777769T patent/ATE359797T1/de active
- 2002-09-26 DK DK02777769T patent/DK1435976T3/da active
- 2002-09-26 CA CA2507926A patent/CA2507926C/en not_active Expired - Lifetime
- 2002-09-26 SI SI200230558T patent/SI1435976T1/sl unknown
- 2002-09-26 JP JP2003530312A patent/JP4613008B2/ja not_active Expired - Lifetime
- 2002-09-26 PT PT02777769T patent/PT1435976E/pt unknown
- 2002-09-26 EP EP02777769A patent/EP1435976B1/en not_active Expired - Lifetime
- 2002-09-26 WO PCT/IS2002/000016 patent/WO2003026677A1/en not_active Ceased
- 2002-09-26 DE DE60219653T patent/DE60219653T2/de not_active Expired - Lifetime
- 2002-09-26 US US10/490,637 patent/US7985741B2/en active Active
-
2004
- 2004-03-22 IS IS7193A patent/IS2783B/is unknown
-
2011
- 2011-06-20 US US13/164,397 patent/US8415326B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IS6085A (is) | 2003-03-27 |
| ES2284935T3 (es) | 2007-11-16 |
| WO2003026677A1 (en) | 2003-04-03 |
| CA2507926C (en) | 2011-12-20 |
| CA2507926A1 (en) | 2003-04-03 |
| US20050004073A1 (en) | 2005-01-06 |
| IS2783B (is) | 2012-05-15 |
| PT1435976E (pt) | 2007-06-28 |
| DK1435976T3 (da) | 2007-08-27 |
| EP1435976B1 (en) | 2007-04-18 |
| US20110257381A1 (en) | 2011-10-20 |
| DE60219653D1 (de) | 2007-05-31 |
| DE60219653T2 (de) | 2008-01-03 |
| KR20040062548A (ko) | 2004-07-07 |
| JP4613008B2 (ja) | 2011-01-12 |
| IS7193A (is) | 2004-03-22 |
| US7985741B2 (en) | 2011-07-26 |
| EP1435976A1 (en) | 2004-07-14 |
| JP2005507891A (ja) | 2005-03-24 |
| US8415326B2 (en) | 2013-04-09 |
| ATE359797T1 (de) | 2007-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1435976T1 (sl) | Farmacevtski sestavek, ki obsega hito-oligomere | |
| CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
| EP2085780A3 (en) | Methods and products related to low molecular weight heparin | |
| WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
| AU2003901834A0 (en) | Cross-linked polysaccharide compositions | |
| PT1420801E (pt) | Utilização de fucanos no tratamento de adesões, artrite e psoríase | |
| CA2339290A1 (en) | Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions | |
| AU5062299A (en) | Formulations of anionic polysaccharides | |
| WO2004105737A3 (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| MY142376A (en) | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them | |
| ES2161615A1 (es) | Composiciones de heparinas de muy bajo peso molecular. | |
| NO20056161L (no) | Formuleringer for behandling av artrittilstander | |
| YU67900A (sh) | Sukcinamidni inhibitori interleukin-1beta konvertujućeg enzima | |
| PL346143A1 (en) | Tan-1057 derivatives | |
| IL157050A0 (en) | 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry | |
| WO2003032925A3 (en) | Glycosulfopeptide inhibitors and methods of use thereof | |
| ITMI20021801A1 (it) | Prodotti di pomodoro. | |
| TW200510012A (en) | Aqua gel comprising temperature effect | |
| ZA974366B (en) | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. | |
| IT1314768B1 (it) | Processo per la produzione di additivi antifiamma per composizionipolimeriche,e prodotti ottenuti da detto processo | |
| EP2301554A8 (en) | Composition for the treatment of osteoarthritis | |
| EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
| ATE552004T1 (de) | Oral verabreichbare heparinderivate | |
| WO2002068056A3 (en) | Combination comprising a 1,4-dioxonaphathalene compound and ribenoside | |
| WO2000029433A3 (en) | 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines |